A study shows large language models can predict immunotherapy responses in liver cancer as accurately as experienced doctors.
Key Details
- 1Research led by Prof. Hai Li at Hefei Institutes systematically assessed LLMs' ability to predict liver cancer treatment response.
- 2LLMs tested: GPT-4, GPT-4o, Google Gemini, DeepSeek, and a hybrid Gemini-GPT model.
- 3Dataset included clinical and imaging data from 186 unresectable HCC patients.
- 4Gemini-GPT matched senior (15+ years) doctor accuracy and surpassed less-experienced clinicians in both speed and accuracy.
- 5Hybrid and logical strategies improved LLM performance and consistency, especially in identifying likely responders to therapy.
- 6Published in the Journal of Medical Systems on May 15, 2025.
Why It Matters
This work demonstrates the emerging capability of LLMs to support and enhance personalized cancer treatment decisions, showing they can complement or even match the expertise of experienced radiologists and oncologists in outcome prediction.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.